Veer Bhavnagri - 15 Jun 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
General Counsel
Signature
Veer Bhavnagri
Issuer symbol
ALLO
Transactions as of
15 Jun 2021
Net transactions value
-$115,250
Form type
4
Filing time
16 Jun 2021, 17:00:12 UTC
Previous filing
20 May 2021
Next filing
16 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Options Exercise $11,350 +5,000 +1.2% $2.27 426,353 15 Jun 2021 Direct
transaction ALLO Common Stock Sale $126,600 -5,000 -1.2% $25.32* 421,353 15 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Options Exercise $0 -5,000 -3.8% $0.000000 127,300 15 Jun 2021 Common Stock 5,000 $2.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020.
F2 25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.